{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T08:35:11Z","timestamp":1768034111285,"version":"3.49.0"},"reference-count":18,"publisher":"Galenos Yayinevi","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["tjod"],"published-print":{"date-parts":[[2023,9,1]]},"DOI":"10.4274\/tjod.galenos.2023.05942","type":"journal-article","created":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T11:57:03Z","timestamp":1693828623000},"page":"174-178","source":"Crossref","is-referenced-by-count":1,"title":["Role of acetyl-CoA acetyltransferase 1 expression in the molecular mechanism of adenomyosis"],"prefix":"10.4274","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9073-5611","authenticated-orcid":false,"given":"Cem","family":"Yalaza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1270-2408","authenticated-orcid":false,"given":"Efsun","family":"Antmen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3863-962X","authenticated-orcid":false,"given":"Necmiye","family":"Canacankatan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6506-9461","authenticated-orcid":false,"given":"Ferah","family":"Tuncel Dalo\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2553-7715","authenticated-orcid":false,"given":"Hakan","family":"Aytan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1988-8674","authenticated-orcid":false,"given":"Sema","family":"Erden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2811","published-online":{"date-parts":[[2023,9,1]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"3410","DOI":"10.3390\/jcm10153410","article-title":"Current and Prospective Treatment of Adenomyosis","volume":"10","author":"Sharara","year":"2021","unstructured":"Sharara FI, Kheil MH, Feki A, Rahman S, Klebanoff JS, Ayoubi JM, et al. Current and Prospective Treatment of Adenomyosis. J Clin Med 2021;10:3410.","journal-title":"J Clin Med"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1093\/molehr\/gal076","article-title":"Molecular characterization of human adenomyosis","volume":"12","author":"Hever","year":"2006","unstructured":"Hever A, Roth RB, Hevezi PA, Lee J, Willhite D, White EC, et al. Molecular characterization of human adenomyosis. Mol Hum Reprod 2006;12:737-48.","journal-title":"Mol Hum Reprod"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3892\/mco.2018.1660","article-title":"Coexistence of adenomyosis, adenocarcinoma, endometrial and myometrial lesions in resected uterine specimens","volume":"9","author":"Tetikkurt","year":"2018","unstructured":"Tetikkurt S, \u00c7elik E, Ta\u015f H, Cay T, I\u015fik S, Usta AT. Coexistence of adenomyosis, adenocarcinoma, endometrial and myometrial lesions in resected uterine specimens. Mol Clin Oncol 2018;9:231-7.","journal-title":"Mol Clin Oncol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.rbmo.2017.06.016","article-title":"Pathogenesis of adenomyosis: an update on molecular mechanisms","volume":"35","author":"Vannuccini","year":"2017","unstructured":"Vannuccini S, Tosti C, Carmona F, Huang SJ, Chapron C, Guo SW, et al. Pathogenesis of adenomyosis: an update on molecular mechanisms. Reprod Biomed Online 2017;35:592-601.","journal-title":"Reprod Biomed Online"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"116592","DOI":"10.1016\/j.lfs.2019.116592","article-title":"The recent insights into the function of ACAT1: A possible anti-cancer therapeutic target","volume":"232","author":"Goudarzi","year":"2019","unstructured":"Goudarzi A. The recent insights into the function of ACAT1: A possible anti-cancer therapeutic target. Life Sci 2019;232:116592.","journal-title":"Life Sci"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1002\/humu.23831","article-title":"Mutation update on ACAT1 variants associated with mitochondrial acetoacetyl-CoA thiolase (T2) deficiency","volume":"40","author":"Abdelkreem","year":"2019","unstructured":"Abdelkreem E, Harijan RK, Yamaguchi S, Wierenga RK, Fukao T. Mutation update on ACAT1 variants associated with mitochondrial acetoacetyl-CoA thiolase (T2) deficiency. Hum Mutat 2019;40:1641-63.","journal-title":"Hum Mutat"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"4932","DOI":"10.3390\/nu14224932","article-title":"Molecular Mechanisms for Ketone Body Metabolism, Signaling Functions, and Therapeutic Potential in Cancer","volume":"14","author":"Hwang","year":"2022","unstructured":"Hwang CY, Choe W, Yoon KS, Ha J, Kim SS, Yeo EJ, et al. Molecular Mechanisms for Ketone Body Metabolism, Signaling Functions, and Therapeutic Potential in Cancer. Nutrients 2022;14:4932.","journal-title":"Nutrients"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.7150\/jca.38598","article-title":"Role of de novo cholesterol synthesis enzymes in cancer","volume":"11","author":"Yang","year":"2020","unstructured":"Yang J, Wang L, Jia R. Role of de novo cholesterol synthesis enzymes in cancer. J Cancer 2020;11:1761-7.","journal-title":"J Cancer"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/pros.22758","article-title":"Evaluation and prognostic significance of ACAT1 as a marker of prostate cancer progression","volume":"74","author":"Saraon","year":"2014","unstructured":"Saraon P, Trudel D, Kron K, Dmitromanolakis A, Trachtenberg J, Bapat B, et al. Evaluation and prognostic significance of ACAT1 as a marker of prostate cancer progression. Prostate 2014;74:372-80.","journal-title":"Prostate"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41586-019-0987-8","article-title":"Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma","volume":"567","author":"Jiang","year":"2019","unstructured":"Jiang Y, Sun A, Zhao Y, Ying W, Sun H, Yang X, et al. Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma. Nature 2019;567:257-61.","journal-title":"Nature"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1074\/mcp.M112.023887","article-title":"Quantitative proteomics reveals that enzymes of the ketogenic pathway are associated with prostate cancer progression","volume":"12","author":"Saraon","year":"2013","unstructured":"Saraon P, Cretu D, Musrap N, Karagiannis GS, Batruch I, Drabovich AP, et al. Quantitative proteomics reveals that enzymes of the ketogenic pathway are associated with prostate cancer progression. Mol Cell Proteomics 2013;12:1589-601.","journal-title":"Mol Cell Proteomics"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"3964","DOI":"10.4161\/cc.22137","article-title":"Ketone body utilization drives tumor growth and metastasis","volume":"11","author":"Martinez-Outschoorn","year":"2012","unstructured":"Martinez-Outschoorn UE, Lin Z, Whitaker-Menezes D, Howell A, Sotgia F, Lisanti MP. Ketone body utilization drives tumor growth and metastasis. Cell Cycle 2012;11:3964-71.","journal-title":"Cell Cycle"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.molcel.2016.10.014","article-title":"Tetrameric Acetyl-CoA Acetyltransferase 1 Is Important for Tumor Growth","volume":"64","author":"Fan","year":"2016","unstructured":"Fan J, Lin R, Xia S, Chen D, Elf SE, Liu S, et al. Tetrameric Acetyl-CoA Acetyltransferase 1 Is Important for Tumor Growth. Mol Cell 2016;64:859-74.","journal-title":"Mol Cell"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.molcel.2016.11.023","article-title":"Drugging ACAT1 for Cancer Therapy","volume":"64","author":"Garcia-Bermudez J","year":"2016","unstructured":"Garcia-Bermudez J, Birsoy K. Drugging ACAT1 for Cancer Therapy. Mol Cell 2016;64:856-7.","journal-title":"Mol Cell"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.mehy.2014.11.002","article-title":"Starvation of cancer via induced ketogenesis and severe hypoglycemia","volume":"84","author":"Kapelner","year":"2015","unstructured":"Kapelner A, Vorsanger M. Starvation of cancer via induced ketogenesis and severe hypoglycemia. Med Hypotheses 2015;84:162-8.","journal-title":"Med Hypotheses"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"667673","DOI":"10.3389\/fonc.2021.667673","article-title":"Epigenetic Inactivation of Acetyl-CoA Acetyltransferase 1 Promotes the Proliferation and Metastasis in Nasopharyngeal Carcinoma by Blocking Ketogenesis","volume":"11","author":"Lu","year":"2021","unstructured":"Lu Y, Zhou X, Zhao W, Liao Z, Li B, Han P, et al. Epigenetic Inactivation of Acetyl-CoA Acetyltransferase 1 Promotes the Proliferation and Metastasis in Nasopharyngeal Carcinoma by Blocking Ketogenesis. Front Oncol 2021;11:667673.","journal-title":"Front Oncol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41435-023-00202-1","article-title":"ACAT1-mediated METTL3 acetylation inhibits cell migration and invasion in triple negative breast cancer","volume":"24","author":"Zhang","year":"2023","unstructured":"Zhang G, Huang R, Zhao H, Xia Y, Huang H, Qian M, et al. ACAT1-mediated METTL3 acetylation inhibits cell migration and invasion in triple negative breast cancer. Genes Immun 2023;24:99-107.","journal-title":"Genes Immun"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1007\/s00404-020-05742-9","article-title":"Altered VEGF, Bcl-2 and IDH1 expression in patients with adenomyosis","volume":"302","author":"Yalaza","year":"2020","unstructured":"Yalaza C, Canacankatan N, G\u00fcrses \u0130, Aytan H, Ta\u015fdelen B. Altered VEGF, Bcl-2 and IDH1 expression in patients with adenomyosis. Arch Gynecol Obstet 2020;302:1221-7.","journal-title":"Arch Gynecol Obstet"}],"container-title":["Journal of Turkish Society of Obstetric and Gynecology"],"original-title":[],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T13:09:31Z","timestamp":1717679371000},"score":1,"resource":{"primary":{"URL":"https:\/\/tjoddergisi.org\/articles\/doi\/tjod.galenos.2023.05942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,1]]},"references-count":18,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,9,1]]},"published-print":{"date-parts":[[2023,9,1]]}},"URL":"https:\/\/doi.org\/10.4274\/tjod.galenos.2023.05942","relation":{},"ISSN":["1307-699X","2149-9330"],"issn-type":[{"value":"1307-699X","type":"print"},{"value":"2149-9330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,1]]}}}